Skip to main content

Featured

5 Things to Know Today: US CPI, BoC Minutes, Oil Below US$90 (Nov. 10)

  Tuesday, November 10, 2026. U.S. inflation data, Bank of Canada minutes and a sharp slide in oil headline your morning. Here is what matters for your wallet. 1. US inflation report lands at 8:30 a.m. ET Economists expect October U.S. consumer prices to rise 0.3% from September, slower than the 0.6% jump the month before, with core prices up 0.2%. There will be no annual rate this time because last year's government shutdown left a gap in the October 2025 data. Strong U.S. jobs numbers on Friday have already pushed the odds of a Fed rate hike on December 9 above 65%. What it means for you: U.S. rate expectations move Canadian bond yields, which set fixed mortgage rates, and they swing the loonie. A hot reading could push yields higher; a cool one could give borrowers a little breathing room. 2. Bank of Canada releases its rate-hike minutes at 1:30 p.m. ET The central bank publishes its summary of deliberations on the October 28 decision, when it raised its policy rate by a qua...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment